Press Releases Year None202220212020201920182017201620152014 AstraZeneca to create stand-alone company for small molecule early stage antibiotic R&D Feb 26, 2015 ETX0914 (AZD0914) designated a Qualified Infectious Disease Product (QIDP) and given Fast Track status by US FDA Jun 03, 2014 Pagination First page « first Previous page ‹ previous … Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 Page 10 Current page 11 Displaying 101 - 102 of 102
ETX0914 (AZD0914) designated a Qualified Infectious Disease Product (QIDP) and given Fast Track status by US FDA Jun 03, 2014